Skip to main content

Blog

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel

...

Double your impact in advancing the research evolution by the end of 2024

...

Give before midnight TONIGHT to double your impact in developing PPMD’s DCRN

...

Together, let’s advance the research evolution

...

Life is about time and timing when living with Duchenne

...

WATCH: Sevasemten – CANYON Trial Topline Results (Webinar Recording)

...

Support PPMD’s commitment to moving the science further, faster

...

Percheron Announces Termination of Phase 2B Study of Avicursen for Duchenne

...

Your gift to PPMD is a commitment to accelerating progress

...

PPMD Convenes GI, GU, and Swallowing Experts for Two-Day Workshop

...